Cite
Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer.
MLA
Marantz, A., et al. “Phase II Study of Gemcitabine, 5-Fluorouracil, and Leucovorin in Patients with Pancreatic Cancer.” Seminars in Oncology, vol. 28, no. 3 Suppl 10, June 2001, pp. 44–49. EBSCOhost, https://doi.org/10.1053/sonc.2001.23807.
APA
Marantz, A., Jovtis, S., Almira, E., Balbiani, L., Castilla, J. L., Fein, L., Lewi, D., Pasccon, G., Pinckevicius, R., Uranga, G., Abal, M., Muiño, M., Reale, M., & Agusto, S. (2001). Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer. Seminars in Oncology, 28(3 Suppl 10), 44–49. https://doi.org/10.1053/sonc.2001.23807
Chicago
Marantz, A, S Jovtis, E Almira, L Balbiani, J L Castilla, L Fein, D Lewi, et al. 2001. “Phase II Study of Gemcitabine, 5-Fluorouracil, and Leucovorin in Patients with Pancreatic Cancer.” Seminars in Oncology 28 (3 Suppl 10): 44–49. doi:10.1053/sonc.2001.23807.